m 4 Biobank Alliance & m 4 Trial Service Center

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "m 4 Biobank Alliance & m 4 Trial Service Center"

Transcription

1 m 4 Biobank Alliance & m 4 Trial Service Center Services & Consulting in (non-)clinical development

2 m 4 Biobank Alliance Central Access to High Quality Human Biospecimens for R&D

3 The m 4 Biobank Alliance Cooperation Network One-stop Access to Samples of Different Biobanks Source: Department for Pathology, TUM Source: Fotolia The m 4 Biobank Alliance provides access to tissue samples (formalin fixed, fresh and frozen) and to blood samples. Source: Fotolia

4 SERVICES of the m 4 Biobank Alliance Our partner biobanks offer Archive of > tissue and blood based specimens, also matched Broad spectrum of indications Prospective collection according to the user s specifications Source: Department for Pathology, TUM Clinical and anamnetic data, follow up data on demand Analytical services The contact person at Bio M provides an all-round service Single project agreement for all partner-biobanks QA for uniform, high quality of samples and data Coordination of sample and data allocation Scientific and clinical consulting Compliance with high standards for ethics and privacy protection

5 m 4 Biobank Alliance & m 4 Trial Service Center Two Strong Partners for Successful Translation Through close collaboration, m 4 Biobank Alliance and m 4 Trial Service Center offer comprehensive resources for the translation of your project from preclinical to clinical development.

6 m 4 Trial Service Center We guide your project from nonclinical to clinical development!

7 m 4 Trial Service Center (TSC) Our mission We navigate you through the translational development! clinical development nonclinical development Nonclinical development Nonclinical drug development stategies Study designs, planning & management Data review / gap analysis Regulatory documentation Trial preparation Project management Clinical trial protocol Regulatory documentation Consulting on demand Clinical trial Sponsor project management Integration of service providers and study sites Consutling on demand, e.g. regarding monitoring, etc.

8 Our approach Experienced consultants plus a strong network Consulting & resources for your project from a single source! Prof. U. Mansmann Regulatory Biostatistics CROs & Labs Clinicians & Clinical developers Early clinical trial facilities Study sites

9 m 4 Trial Service Center (TSC) Our team: Consultants with longstanding experience Dr. Anneliese Schneider 15+ years industry experience in drug discovery and nonclinical development Senior Expert in Tox, PK, PD (Board Certified) We are your local experts! Lena Mokelke, Dipl.-Biol. 10+ years industry experience in clinical trials Strong project management skills Dr. Martin Sippel Expertise in early drug development Project management and industry consulting experience

10 Selection of references Guidance and services for successful translational development Translational development (I): Comprehensive guidance in the preparation of a Phase I trial We provided advice on the preclinical programs required for the start of clinical development We established a roadmap to enter the clinical trial: Timelines, Roles & Responsibilities, The roadmap was put into practice by our experienced project manager Development and writing of the clinical trial protocol, with mulitdisciplinary input from our network of specialists We also involved service providers from our network Important: Long-term experience of our team to avoid pitfalls!

11 Selection of references Guidance and services for successful translational development Translational development (II): Early advice on preclinical & clinical development strategy Preclinical advice: Results from tox studies were assessed by our team expert By overseeing the whole development process, we assure that regulatory requirements are met Very important: Advice on clinical strategy involvement of experts for the relevant indications from our network

12 Selection of references Guidance and services for successful translational development Preclinical development: General assessment of preclinical program Overall assessment and data evaluation of preclinical safety & pharmacology studies Input by our experienced team expert: Verification of conclusions from preclinical data Advice and recommendations for further procedures in nonclinical development

13 Selection of references Guidance and services for successful translational development For advanced researchers: Our review service Example: clinical trial protocol optimization Our team expert for clinical development initiated study design optimizations during in-depths discussions In close cooperation with our biostatistics partner Prof. Mansmann, we adjusted the number of patients for sufficient statistical power. Also, we enhanced the clarity of trial procedures described in the protocol, leading to a more comprehensive description for study personnel potential for protocol violations is diminished!

14 Selection of references Guidance and services for successful translational development Other topics we advised upon Interaction with authorities Drug-drug interactions, DMPK for small molecules Validation of assays in Personalized Medicine: QM issues for laboratories (in close cooperation with QM experts from our network) Technical validation of assay Clinical validation strategy, trial preparation

15 Thank you! How can we support you? Get in touch with us! Dr. Martin Sippel Phone +49 (0) Mail Web

Mayo Alliance for Clinical Trials

Mayo Alliance for Clinical Trials Mayo Alliance for Clinical Trials A Division within Mayo Clinical Trial Services PROFESSIONAL CLINICAL TRIALS SERVICES ADVANCING PATIENT CARE THROUGH SCIENTIFIC DISCOVERY It is a great thing to make scientific

More information

DESIGN & ENDPOINT OF PHASE I / TRANSLATIONAL RESEARCH MONDAY 7 TH JULY 2014 UZMA RAYANI CLINICAL OPERATIONS MANAGER

DESIGN & ENDPOINT OF PHASE I / TRANSLATIONAL RESEARCH MONDAY 7 TH JULY 2014 UZMA RAYANI CLINICAL OPERATIONS MANAGER DESIGN & ENDPOINT OF PHASE I / TRANSLATIONAL RESEARCH MONDAY 7 TH JULY 2014 UZMA RAYANI CLINICAL OPERATIONS MANAGER Drug Development Office 100 DRUG DEVELOPMENT AND OPERATIONAL STAFF NEW AGENTS IN CLINICAL

More information

BIOBANK QUALITY. dcarpentieri@phoenixchildrens.com Office: 602-546-1285

BIOBANK QUALITY. dcarpentieri@phoenixchildrens.com Office: 602-546-1285 BIOBANK QUALITY David F Carpentieri, M.D. Pediatric Pathologist and Biorepository Director, Phoenix Children s Hospital Assistant Professor of Pediatrics and Clinical Pathology, University of Arizona Assistant

More information

Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services

Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services LABORATORY TESTING SERVICES YOUR PARTNER IN LABORATORY MEDICINE The key note of progress in the 20th century is

More information

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:

More information

Organization and Job Profile

Organization and Job Profile Organization and Job Profile New Orleans, Louisiana Position: Reports to: Location: System Vice President for Research New Orleans, Louisiana CORPORATE BACKGROUND is a non-profit, academic, multi-specialty,

More information

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA Lilly Covance Strategic Alliance From Vision to Results Adrienne Takacs, PhD Jonathan Koch, MBA Topics 1. Lilly s Challenge... a Partnership Opportunity 2. Our Landmark Agreement 3. A Local Success Story

More information

Sheffield Kidney Institute. Planning a Clinical Trial

Sheffield Kidney Institute. Planning a Clinical Trial Planning a Clinical Trial Clinical Trials Testing a new drug Ethical Issues Liability and Indemnity Trial Design Trial Protocol Statistical analysis Clinical Trials Phase I: Phase II: Phase III: Phase

More information

Professional Certificate in Primary Care Psychology

Professional Certificate in Primary Care Psychology Professional Certificate in Primary Care Psychology The NAPPP Primary Care Psychology Certificate training program requires the completion of 10 courses. Each course awards 15 CE credit hours. NAPPP is

More information

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality

More information

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within

More information

SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS

SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS UDC 615:519.076 Dobrova V. Ye., Zupanets K. O., Ratushna K. L. National University of Pharmacy SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL

More information

Requirements of mouse models by Pharmaceutical Industry. EFPIA opinions

Requirements of mouse models by Pharmaceutical Industry. EFPIA opinions Requirements of mouse models by Pharmaceutical Industry. EFPIA opinions INFRAFRONTIER meeting Barcelona, November 13 th 2014 Eduard Valenti ESTEVE Disclaimer Informations compiled in this presentation

More information

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA PharmaSUG 2014 Paper CP07 Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA ABSTRACT In the biopharmaceutical

More information

I. INTRODUCTION DEFINITIONS AND GENERAL PRINCIPLE

I. INTRODUCTION DEFINITIONS AND GENERAL PRINCIPLE Final: Approved by Partners Professional and Institutional Conduct Committee 8/11/04 Policy on Transfers to Third Parties Of Tissues, Other Specimens, and Data Obtained by Partners-Affiliated Providers

More information

Medical Psychology Certificate Program Information

Medical Psychology Certificate Program Information Medical Psychology Certificate Program Information The Medical Psychology Professional Certificate Program requires the completion of 10 courses for a total of 300 hours. The program is consistent with

More information

CTRNet Standard Operating Procedure Job Descriptions, Roles and Responsibilities

CTRNet Standard Operating Procedure Job Descriptions, Roles and Responsibilities CTRNet Standard Operating Procedure SOP Number: 01.006 Version: e2.0 Supersedes: 1.1.102 e1.0 Category: Administration 1.0 PURPOSE Approved By: CTRNet Management Group Per: Brent Schacter 01-May-2012 28-May-2012

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Site Initiation and Close Out (Sponsored Clinical Trials)

Site Initiation and Close Out (Sponsored Clinical Trials) Site Initiation and Close Out (Sponsored Clinical Trials) Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 008 Version number: 1 Effective date: 01 June

More information

National Cancer Institute

National Cancer Institute National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Taking Part in Cancer Treatment Research Studies If

More information

Contact. Laboratory for Clinical Trials Laboratoire des Essays Cliniques Laboratorio de Ensayos Clinicos

Contact. Laboratory for Clinical Trials Laboratoire des Essays Cliniques Laboratorio de Ensayos Clinicos Contact LKF - Laboratorium für Klinische Forschung GmbH Lise-Meitner-Straße 25-29 D-24223 Raisdorf, Germany Phone: +49(0)43 07-82 76 0 Fax: +49(0)43 07-82 76 79 Internet: www.lkf-kiel.de E-mail: project@lkf-kiel.de

More information

Seeds Finding, Incubation and Evaluation

Seeds Finding, Incubation and Evaluation The REACTA FORUM November 26-27, 2015 Chiba, Japan, Chiba University School of Medicine Memorial Hall Seeds Finding, Incubation and Evaluation -Role of the Core Clinical Center in ARO Network- Kohei Ueda

More information

Comprehensive Sample Management Solutions

Comprehensive Sample Management Solutions Comprehensive Sample Management Solutions Discover the Hidden Value in Your Sample Assets solutions consulting sample storage sample bioprocessing onsite/offsite operations management logistics/relocation

More information

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT Clinical Research Infrastructure at the European level: the RIN model Christine Kubiak RIN Coordination Inserm- DRCT Finland FinnCRIN Ireland ICRIN UK UKCRN France Inserm Denmark DCRIN Germany KKS Switzerland

More information

IBCSG Tissue Bank Policy

IBCSG Tissue Bank Policy THE INTERNATIONAL BREAST CANCER STUDY GROUP IBCSG Tissue Bank Policy Accepted by the IBCSG Executive Committee on March 24, 2006 Accepted by the IBCSG Ethics Committee on March 24, 2006 Accepted by the

More information

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL

More information

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

25 % RR in premature mortality due to CV diseases Cancer Diabetes COPD Better educated, higher income population which requires modern health care,

25 % RR in premature mortality due to CV diseases Cancer Diabetes COPD Better educated, higher income population which requires modern health care, Education and training of medicines development, regulation and clinical research in Low and Middle Income Countries (LMICs) S. Kerpel-Fronius & B. Rosenkranz Sándor Kerpel-Fronius, M.D., D.Sc. Semmelweis

More information

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.

More information

Annex 7 Guidelines for the preparation of a contract research organization master file

Annex 7 Guidelines for the preparation of a contract research organization master file World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality

More information

Site Initiation and Closeout

Site Initiation and Closeout STANDARD OPERATING PROCEDURE Site Initiation and Closeout Standard Operating Procedure Western Health SOP reference 008 Version: 2.0 dated December 2015 Effective Date Review Date Author: Approved by Mr

More information

IS YOUR PROJECT HUMAN SUBJECTS RESEARCH. A Guide for Investigators. Jacksonville University Institutional Review Board DEFINING RESEARCH

IS YOUR PROJECT HUMAN SUBJECTS RESEARCH. A Guide for Investigators. Jacksonville University Institutional Review Board DEFINING RESEARCH IS YOUR PROJECT HUMAN SUBJECTS RESEARCH? A Guide for Investigators HUMAN SUBJECTS RESEARCH Research projects involving human subjects require review and approval by an Institutional Review Board. An IRB

More information

RESEARCH ETHICS COMMITTEES IN ROMANIA. Assoc. Prof. Beatrice Ioan Gr.T.Popa University of Medicine and Pharmacy Iasi, Romania

RESEARCH ETHICS COMMITTEES IN ROMANIA. Assoc. Prof. Beatrice Ioan Gr.T.Popa University of Medicine and Pharmacy Iasi, Romania RESEARCH ETHICS COMMITTEES IN ROMANIA Assoc. Prof. Beatrice Ioan Gr.T.Popa University of Medicine and Pharmacy Iasi, Romania Legal framework International Helsinki Declaration Oviedo Convention EU directives

More information

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013 Achieving Regulatory Success: Areas of focus for biotechnology companies Michael J. Schlosser, PhD, DABT April 21, 2013 Regulatory Success Outline Regulatory Initiatives Regulatory Science Pre-Regulatory

More information

Guidance for Industry

Guidance for Industry Guidance for Industry End-of-Phase 2A Meetings U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 Procedural Guidance

More information

The Role of the CRO in Effective Risk-Based Monitoring

The Role of the CRO in Effective Risk-Based Monitoring New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging

More information

Future Biobanking- Developing Smart, Sustainable And Ethically Compliant Biorepositories Market Research By MarketResearchReports.

Future Biobanking- Developing Smart, Sustainable And Ethically Compliant Biorepositories Market Research By MarketResearchReports. Future Biobanking- Developing Smart, Sustainable And Ethically Compliant Biorepositories Market Research By MarketResearchReports.Biz MarketResearchReports.Biz Recently Announced Research Report And Forecast

More information

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before

More information

LSUHSC Biospecimen Core

LSUHSC Biospecimen Core LSUHSC Biospecimen Core Historical: Traditionally, research involving human blood and tissues in medical institutions involved collaborative efforts among physicians/surgeons and researchers. Often specimens

More information

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015 BioWales 2015 Pharmaceutical Supply Chain Showcase 04 March 2015 SIMBEC RESEARCH 40 YEARS EXPERIENCE IN EARLY STAGE CLINICAL DRUG DEVELOPMENT BACKGROUND Over 1,200 clinical studies safely and successfully

More information

Template for essential information to be provided for proposals including clinical trials / studies / investigations

Template for essential information to be provided for proposals including clinical trials / studies / investigations Template for essential information to be provided for proposals including clinical trials / studies / investigations Document history Version 2016callsV1 September 2015 Modifications (compared to previous

More information

Role of the Clinical Trial Monitor. Dr Christine Maure

Role of the Clinical Trial Monitor. Dr Christine Maure Role of the Clinical Trial Monitor Dr Christine Maure Monitoring The act of overseeing the progress of a clinical trial, and of ensuring that it is: conducted, recorded, and reported in accordance with

More information

University of California, Irvine. (December 4, 2010, Sapporo, Japan)

University of California, Irvine. (December 4, 2010, Sapporo, Japan) University of California, Irvine 1 2 (December 4, 2010, Sapporo, Japan) This article is an invaluable record of an interview with Prof. Ruth Mulnard, who is a nursing scientist as well as a clinician in

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,

More information

Clinical Data Management Overview

Clinical Data Management Overview The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related

More information

Diagnostic Tests. Brad Spring Director, Regulatory Affairs

Diagnostic Tests. Brad Spring Director, Regulatory Affairs Regulatory Challenges in the Development of Diagnostic Tests Industry Perspective Brad Spring Director, Regulatory Affairs September 28, 2011 Balancing Evidence of Safety & Effectiveness and Time to Market

More information

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency

More information

GOVERNANCE AND THE EHR4CR INSTITUTE

GOVERNANCE AND THE EHR4CR INSTITUTE GOVERNANCE AND THE EHR4CR INSTITUTE Dipak Kalra EuroRec, University College London Christian Ohmann, European Clinical Research Infrastructure Network (ECRIN) Electronic Health Records for Clinical Research

More information

The Art of Auditing Bioanalytical Laboratories

The Art of Auditing Bioanalytical Laboratories Sponsor Audits of Bioanalytical Laboratories One of the critical tasks for a Good Laboratory Practices (GLP) nonclinical laboratory study or Clinical Trial team is choosing a bioanalytical laboratory vendor

More information

Nurse Researcher or Clinical Research Nurse: Understanding the Difference

Nurse Researcher or Clinical Research Nurse: Understanding the Difference Nurse Researcher or Clinical Research Nurse: Understanding the Difference Claudia D. Smith, PhD, RN, NE-BC Director, Nursing Research St. Luke s Medical Center An Alternate Title for the Presentation:

More information

Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity

Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies Appendix I of the Guidelines for the Clinical Translation of Stem Cells www.isscr.org 2008, International Society for Stem Cell Research 2 Introduction We have all

More information

To know more about Pharmacovigilance and Clinical Trials Data Management

To know more about Pharmacovigilance and Clinical Trials Data Management To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding

More information

Statisticians in Pharmaceutical Industry. Hans Ulrich Burger SSG, October 18, 2013

Statisticians in Pharmaceutical Industry. Hans Ulrich Burger SSG, October 18, 2013 Statisticians in Pharmaceutical Industry Hans Ulrich Burger SSG, October 18, 2013 1 Objectives History of biostatisticians in pharmaceutical industry Important roles and tasks in drug development Opportunities

More information

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

Overview of Phase 1 Oncology Trials of Biologic Therapeutics Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of

More information

From The Lab To Your Medicine Cabinet:

From The Lab To Your Medicine Cabinet: From The Lab To Your Medicine Cabinet: A Pharmaceutical Drug s Journey Presented by: Dr. Steven Hansel Sr. Director; Pfizer Moderated by: Sam Gilchrist Ph.D. Candidate; UBC The Drug Development Process

More information

Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research Samples

Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research Samples Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research Samples UKCRC Registered CTUs Network Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research

More information

Quality Biobanking Operations and Practices connecting the biobank with downstream applications increasing the value of your biobank

Quality Biobanking Operations and Practices connecting the biobank with downstream applications increasing the value of your biobank National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Quality Biobanking Operations and Practices connecting the biobank with downstream applications increasing

More information

Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC

Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC ISCT Conference, New Zealand, April 2013 April 1 st 2013 NIBSC will become part of the Medicines and

More information

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities

More information

Good Clinical Practice 101: An Introduction

Good Clinical Practice 101: An Introduction Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological

More information

Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD

Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,

More information

Novartis Investigator Initiated Trials (IITs) Guidelines

Novartis Investigator Initiated Trials (IITs) Guidelines Novartis Investigator Initiated Trials (IITs) Guidelines Introduction and background As part of our commitment to delivering innovative therapies to patients worldwide, Novartis believes in the need to

More information

STANDARD OPERATING POLICY AND PROCEDURE

STANDARD OPERATING POLICY AND PROCEDURE STANDARD OPERATING POLICY AND PROCEDURE SUBJECT: Biospecimen Request and Release Policy Number: 500.0 Policy Date: 1/16/2009 Amendment Date: N/A Revision Date: 5-3-2010 I. INTRODUCTION AND PURPOSE The

More information

Principal Investigator and Sub Investigator Responsibilities

Principal Investigator and Sub Investigator Responsibilities Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal

More information

Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements

Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award

More information

ECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs

ECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs ECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs Ingrid Maes Director Pharma, Healthcare and Life Sciences PwC on behalf of: PwC on behalf of: PwC on behalf of: PwC PwC on behalf of:

More information

The Danish Biobank System a unique resource for biomedical research and development

The Danish Biobank System a unique resource for biomedical research and development The Danish Biobank System a unique resource for biomedical research and development Professor Stephen Hamilton-Dutoit Chair of Pathology, Aarhus University Denmark Denmark a great little country for biobank

More information

Clinical Trial Operations

Clinical Trial Operations Contract Research and Consulting Organisation Consulting Clinical Trial Operations Training Your partner for CLINically remarkable results We are a leading Polish company specializing in clinical research

More information

Global healthcare solutions

Global healthcare solutions Global healthcare solutions clinical trials pharma/biotech medical technology & supplies Global healthcare solutions for your peace-of-mind A global network with specialist options Global presence with

More information

A PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT

A PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT Accelovance 2275 Research Boulevard, Suite 700 Rockville, MD 20850, United States Phone: +1.240.238.4900 Fax: +1.240.238.4901 Internet: www.accelovance.com email: gsmith@accelovance.com Contact Person:

More information

Use advanced techniques for summary and visualization of complex data for exploratory analysis and presentation.

Use advanced techniques for summary and visualization of complex data for exploratory analysis and presentation. MS Biostatistics MS Biostatistics Competencies Study Development: Work collaboratively with biomedical or public health researchers and PhD biostatisticians, as necessary, to provide biostatistical expertise

More information

TEMPLATE DATA MANAGEMENT PLAN

TEMPLATE DATA MANAGEMENT PLAN TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager

More information

NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23)

NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23) NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23) Note: the information below is extracted from the current Program Announcements; before applying for a K award you should obtain and read the most

More information

No. 706. Page 1 of 5. Issue Date 4/21/2014

No. 706. Page 1 of 5. Issue Date 4/21/2014 Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page

More information

Operational aspects of a clinical trial

Operational aspects of a clinical trial Operational aspects of a clinical trial Carlo Tomino Pharm.D. Coordinator Pre-authorization Department Head of Research and Clinical Trial Italian Medicines Agency Mwanza (Tanzania), June 11, 2012 1 Declaration

More information

United States Small Business Administration Office of Hearings and Appeals

United States Small Business Administration Office of Hearings and Appeals Cite as: NAICS Appeal of Information Ventures, Inc., SBA No. NAICS-4882 (2008) United States Small Business Administration Office of Hearings and Appeals NAICS APPEAL OF: Information Ventures, Inc. Appellant

More information

Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT

Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT Regulatory changes will occur for investigators studying human DNA The recent acceleration and widening

More information

TAKING PART IN CANCER TREATMENT RESEARCH STUDIES

TAKING PART IN CANCER TREATMENT RESEARCH STUDIES For more infomation about Cancer Clinical Trials at Upstate Cancer Center please call Upstate Connect 1.800.464.8668 TAKING PART IN CANCER TREATMENT RESEARCH STUDIES Information provided by: National Cancer

More information

Summary of the role and operation of NHS Research Management Offices in England

Summary of the role and operation of NHS Research Management Offices in England Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices

More information

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015 19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All

More information

Introduction to Clinical Research

Introduction to Clinical Research Introduction to Clinical Research NCURA Region I Spring Meeting May 5, 2015 Agenda Introductions Brief History of Clinical Research Clinical Research in Context Clinical Research Compliance Clinical Research

More information

PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group

PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197228/2005 Procedure no.: INS/GCP/2 PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA GCP Inspectors Working Group

More information

Protecting Phase I Subjects IRB Considerations for Phase I Review of Research June 5, 2013

Protecting Phase I Subjects IRB Considerations for Phase I Review of Research June 5, 2013 Webinar Series Protecting Phase I Subjects IRB Considerations for Phase I Review of Research June 5, 2013 Presented by: Julie Blasingim Director of Operations, Clinical Pharmacology About Schulman Associates

More information

An Introduction to Clinical Research

An Introduction to Clinical Research An Introduction to Clinical Research Presented by: Sabrina Ramkellawan March 30, 2016 Getting Started in Clinical Research This webinar is for anyone interested in learning more about the clinical research

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?

More information

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,

More information

EDCTP-TDR Clinical Research and Development Fellowship Training Plan

EDCTP-TDR Clinical Research and Development Fellowship Training Plan EDCTP-TDR Clinical Research and Development Fellowship Training Plan 1 Administrative information Grant reference number Name of Fellow Home organisation, country Supervisor at home organisation Name Job

More information

PPT Presentation on ISO Medical Laboratory Accreditation. - By Punyam Management Services

PPT Presentation on ISO Medical Laboratory Accreditation. - By Punyam Management Services PPT Presentation on ISO 15189 Medical Laboratory Accreditation - By Punyam Management Services Make Effective Presentations Using Awesome Backgrounds Engage your Audience What is ISO 15189? ISO 15189 standard

More information

Enrico Invernizzi Alessandra Grande

Enrico Invernizzi Alessandra Grande Con il contributo educazione di Enrico Invernizzi Alessandra Grande Roma, venerdì 1 marzo 2013 Merck Serono - RBM, Colleretto Giacosa, Italy Outline Regulatory enviroment Biomarkers: What and why Which

More information

Call 2014: High throughput screening of therapeutic molecules and rare diseases

Call 2014: High throughput screening of therapeutic molecules and rare diseases Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for

More information

Balancing Big Data for Security, Collaboration and Performance

Balancing Big Data for Security, Collaboration and Performance Balancing Big Data for Security, Collaboration and Performance Sai Balu Lineberger Cancer Center UNC Chapel Hill Oct 14, 2014 About UNC Oldest Public University -1793 Top 5 Public University. 46th World

More information

Specialty Lab and Immunological Testing Services

Specialty Lab and Immunological Testing Services Specialty Lab and Immunological Testing Services OVER 30 YEARS OF SPECIALTY LAB EXPERIENCE Precision for Medicine recognizes the critical role that sample testing and handling play in achieving high-quality,

More information

CTC Technology Readiness Levels

CTC Technology Readiness Levels CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.

More information

A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations

A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations Ce3, Inc. and Insight Genetics, Inc. Oncology Forum July 15, 2015 Agenda Introductions Definitions Regulations

More information

Regulatory Issues in Genetic Testing and Targeted Drug Development

Regulatory Issues in Genetic Testing and Targeted Drug Development Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types

More information

OCT Practical Aspects of Conducting Clinical Trials for Russian Innovative Companies

OCT Practical Aspects of Conducting Clinical Trials for Russian Innovative Companies OCT Practical Aspects of Conducting Clinical Trials for Russian Innovative Companies Innovative Drug Research and Development in Russia 2012 OCT: CRO in Russia, Central and Eastern Europe Russian Innovative

More information